Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Gaush Meditech Ltd. ( (HK:2407) ) has shared an announcement.
Gaush Meditech Ltd announced that its subsidiary, Gaush Tech Ltd, has obtained a medical device registration certificate in China for its corneal contact lens. This product is designed to be used with confocal ophthalmic laser diagnostic equipment, enhancing the safety and effectiveness of ophthalmic disease diagnosis by preventing cross-infection and ensuring optimal optical performance. The approval is expected to strengthen the company’s position in the ophthalmic diagnostic market, catering to the rising demand driven by an aging population.
More about Gaush Meditech Ltd.
Gaush Meditech Ltd is a company incorporated in the Cayman Islands, operating in the medical technology industry. The company focuses on developing and providing advanced ophthalmic diagnostic equipment and solutions, with a market focus on enhancing diagnostic accuracy and safety in ophthalmology.
Average Trading Volume: 135,439
Technical Sentiment Signal: Hold
Current Market Cap: HK$1.05B
For detailed information about 2407 stock, go to TipRanks’ Stock Analysis page.